SlideShare a Scribd company logo
1 of 43
DIET AND RISKS OF
PARKINSON’S DISEASE
Submitted by: Asal Sadeq
Submitted to: Dr. Salma Tokan
 Introduction:
 Parkinson’s disease (PD) also known as
idiopathic or primary parkinsonism,
hypokinetic rigid syndrome/HRS, or
paralysis agitans, is a chronic and
progressive movement disorder.
 The cause is unknown, and although there
is presently no cure. But there are
medications and surgery to manage its
symptoms.
Parkinson’s involves the malfunction
and death of vital nerve cells in the
brain, called neurons in the an area of
the brain called the substantia nigra.
Which produce dopamine.
Tremor or shaking
Small handwriting
Loss of smell
Trouble sleeping
Trouble moving or walking
Constipation
A soft or low voice
Dizziness or fainting
Stooping or Hunching over
Masked face
Signs of Parkinson’s disease
RISK FACTORS OF PARKINSON'S DISEASE
Age Gender Head
injury
Exposure
to metals
Area of
residence
Occupation
Pesticide
exposure
Solvents
and PCBs Genetic
AGE
About 1% of people over age
60 have Parkinson’s disease
compared with 0.001% of
people 45 or younger.
GENDER
Parkinson’s is more common
in men than in women and it’s
unknown whether this is due to
genetic factors, hormones, or
differences in behavior.
HEAD INJURY
Injury that results in amnesia or
loss of consciousness has
been associated with an
increased risk of developing
Parkinson’s years after the
injury.
EXPOSURE TO METALS
Occupational exposures to
various metals have been
suggested to be related to the
development of PD.
AREA OF RESIDENCE
There are differences in the
geographic distribution of PD.
These could be due to
differences in environmental
factors.
OCCUPATION
Certain occupational
categories or job titles have
been associated with a higher
incidence of PD, but results
have been inconsistent.
PESTICIDE EXPOSURE
Of all chemical exposures that
have been linked to
Parkinson's, pesticides have
been reported the most
consistently.
SOLVENTS AND TCE
Occupational exposure to TCE
was found to be associated
with Parkinson's among
workers whose factory results
in long term exposure to the
solvent.
GENETIC PREDISPOSITION
Person’s genetic makeup will
help to determine the effect of
an environmental exposure.
PROTECTIVE FACTORS
Caffeine
Uric acid
or urate
Nicotine
CholesterolVitamin D
Antioxidant
and
mediterrean
diet
Exercise
CAFFEINE
There have been several recent
studies suggesting that caffeine may
reduce the risk of Parkinson's disease.
And there is a new study suggesting
that caffeine may be a reasonable
treatment for the Parkinson's disease
motor symptoms. ( Dr. Michael S. Okun,
2012)
ASSOCIATIONS OF PARKINSON'S DISEASE WITH CONSUMPTION OF TEA, DECAFFEINATED COFFEE,
AND COLA DRINKS, WESTERN WASHINGTON STATE, 1992–2000
AM J EPIDEMIOL VOL. 155, NO. 8, 2002))
95% CIOR*no. of
controls
no. of
cases
Tea
(cups/day)
0.6- 1.31.0202138Almost
never
0.2-0.90.811061>0-1
0.0320.43511>= 2
URIC ACID OR URATE
Uric acid is a natural antioxidant that may
reduce oxidative stress, a mechanism
thought to play a role in the pathogenesis of
PD. Higher levels of serum urate may have
a neuroprotective effect. High SU levels
reduced the risk of developing PD and
correlated with slower PD progression.
Among PD patients SU level were lower as
compared with controls. (Ilana Schlesinger,
2008)
NICOTINE
Both retrospective and prospective
epidemiological studies have
consistently demonstrated an inverse
association between cigarette smoking
and PD, leading to theories that
smoking in general and nicotine in
particular might be neuroprotective.
(ross GW, 2011)
ASSOCIATIONS OF PARKINSON'S DISEASE WITH CIGARETTE SMOKING,
WESTERN WASHINGTON STATE, 1992–2000
( AM J EPIDEMIOL,2002)
95% CIOR*No. of
controls
No. of
cases
Smoking
status
1.0132112Never
smoked
0.4-0.80.521598Ever
smoked
0.1-0.70.3367Current
smoker
0.4-0.90.617991EX-
smoker
CHOLESTEROL LEVELS
 Statins are among the most widely used
drug around the world. Beyond lowering
cholesterol they are known to fight
inflammation and oxidative stress.
 When they get into your brain they likely
modify the brain’s immune system, Lessing
your risk of PD
 Finding that when people on certain statins
stop taking them, their risk of developing PD
is higher. (Lee-YC, 2013)
VITAMIN D
Two studies of vitamin D and
Parkinson’s indicate that those with
PD have lower vitamin D blood levels
than those without PD.
Vitamin D may also reduce
inflammation in the brain.
(ARCH NEUROL. 2008)
ANTIOXIDANTS AND MEDITERRANEAN DIET
 Antioxidants “soak up” or scavenge free
radicals.
 Vitamin C and E are antioxidants that fight
free radicals, and may protect brain cells.
 Dietary sources include whole grains, wheat
germ, avocados, nuts and vegetable oil.
MEDITERRANEAN DIET
There is some evidence that the
Mediterranean diet, a diet high in
monounsaturated fats, may be
beneficial in reducing blood pressure
and cardiovascular disease.
The diet emphasizes fish, especially
those high in Omega 3 fatty acids, and
food containing antioxidant.
EXERCISE
Greater physical activity has been
associated with lower risk of
Parkinson's studies in animals
also support this.
PARKINSON’S AND GASTROINTESTINAL
DIFFICULTIES
Scientists point to two explanations for
these difficulties:
The same brain changes in PD cause
stiffness and slow of movement.
PD affect the nerves that line the
digestive tract, called the enteric
nervous system.
GI
difficulties
Dysphagia
nausea
constipation
Bladder
problem
DIFFICULTIES SWALLOWING
“DYSPHAGIA”
People with Parkinson's tend to
swallow less often and less
completely, and as a result some 70%
have too much saliva, which often
pools in their mouth. (Ron Pfeiffer, 2008)
CONTROLLING SWALLOWING
Sucking in
hard
candies
A atropine
eye drops
Anti-
Parkinson’s
medication
NAUSEA
Nausea or bloating can result when
the stomach empties its content into
the small intestine too slowly, a
condition called gastroparesis. (Ron
Pfeiffer, M.D.,2008)
CONTROLLING NAUSEA
 Avoid orange or acidic beverages
 Drink beverages slowly
 Avoid fried or sweet food
 Eat slowly
 Eat small and frequent meals
 Try to eat when you feel lees nauseated
 Rest after eating
 Eat light, bland food
 Don’t mix cold and hot food
CONSTIPATION
 It’s defined as fewer than three bowel movements
per week, is perhaps the most widely recognized
gastrointestinal symptom of Parkinson’s disease.
 In some people with PD, constipation may occur
due to the improper functioning of the autonomic
nervous system which is responsible for regulating
smooth muscle activity.
 Medications used to treat Parkinson’s disease can
also cause constipation. (Ron Pfeiffer, M.D., 2008)
TO AVOID CONSTIPATION
 Eat a well-balanced diet with plenty of fiber
 Dink a plenty of water
 Exercise daily
 Drink warm liquids, especially in the
morning
 Add fruits and vegetables to your diet
 Eat whole grain food
BLADDER PROBLEMS
People with PD may also have bladder
problems. The most common difficulty
is a frequent and urgent need to
urinate, even when the bladder is not
full. (Ron Pfeiffer, 2008)
DRUGS USED TO TREAT PARKINSON'S
Carbidopa-levodopa
Dopamine agonists
MAO inhibitors
COMT inhibitors
LEVODOPA-CARBIDOPA
It’s converted by enzyme in the brain
to produce dopamine.
Levodopa is most frequent combined
with Carbidopa.
But levodopa has not seen to slow
disease progression. And this drug has
a side effects including: dyskinesia,
hallucinations, illusions, nausea, and
lightheadedness.
DOPAMINE AGONISTS
These drugs don’t convert to
dopamine in the brain, but instead
mimic the effect of dopamine on the
brain.
May cause side effects like: daytime
sleeping, hallucinations and risk taking
behavior.
MAO INHIBITORS
 MAO Inhibitors drugs inhibit an enzyme that breaks
down Levodopa thus extending its action.
 Used alone or in combination with levodopa-
carbidopa, but when added to it, the medications
increases the risk of hallucinations.
 They have side effects like: the drug may have
interactions with other medications and food, blood
pressure issues must be monitored carefully, also
they may have interaction with antidepressant.
COMT INHIBITORS
 Catechol O-methyltransferase (COMT)
inhibitors allow a larger amount of levodopa
to reach the brain, thus raising the
dopamine levels there.
 Used in conjunction with levodopa-
carbidopa.
 Side effects include: dyskinesia,
hallucination mainly from an enhanced
levodopa effect.
DIETARY GUIDELINES FOR PD
PATIENTS
Eating regularly
Try to limit sugars
Moderate use of salt
Drink 8 glasses of water per day
Diet should includes plenty of calcium
and Vitamin D
Diet should includes foods high in
fiber.
my seminar p.p

More Related Content

What's hot

Dopa Responsive Dystonia
Dopa Responsive DystoniaDopa Responsive Dystonia
Dopa Responsive DystoniaAde Wijaya
 
Coffee Health Effects and Bioactive compounds
Coffee Health Effects and Bioactive compoundsCoffee Health Effects and Bioactive compounds
Coffee Health Effects and Bioactive compoundsPedram Shokouh
 
Lennox Gastaut Syndrome- by Rxvichu :)
Lennox Gastaut Syndrome- by Rxvichu :)Lennox Gastaut Syndrome- by Rxvichu :)
Lennox Gastaut Syndrome- by Rxvichu :)RxVichuZ
 
The Importance of Nutrition for Mental Health: Dr. Alex Richardson -
The Importance of Nutrition for Mental Health: Dr. Alex Richardson - The Importance of Nutrition for Mental Health: Dr. Alex Richardson -
The Importance of Nutrition for Mental Health: Dr. Alex Richardson - TheAdlerSchool
 
LGS Foundation 2016 Conference - Friday Morning
LGS Foundation 2016 Conference - Friday MorningLGS Foundation 2016 Conference - Friday Morning
LGS Foundation 2016 Conference - Friday MorningLGS Foundation
 
Leigh Syndrome - Mary Kay Koenig, MD
Leigh Syndrome - Mary Kay Koenig, MDLeigh Syndrome - Mary Kay Koenig, MD
Leigh Syndrome - Mary Kay Koenig, MDmitoaction
 
Alzheimer's
Alzheimer'sAlzheimer's
Alzheimer'selaf86
 
Caffeine presentation
Caffeine presentationCaffeine presentation
Caffeine presentationJayanta Pal
 
Caffeine & ITS effect on brain
Caffeine & ITS effect on brainCaffeine & ITS effect on brain
Caffeine & ITS effect on brainKeerti Maheshwari
 
Autoimmune epilepsy
Autoimmune epilepsy Autoimmune epilepsy
Autoimmune epilepsy Ade Wijaya
 
Supplement manual mass
Supplement manual massSupplement manual mass
Supplement manual masslizstockbridge
 
DrRic Whole Foods Market Schaumburg Nutrition and Mental Health (slide share ...
DrRic Whole Foods Market Schaumburg Nutrition and Mental Health (slide share ...DrRic Whole Foods Market Schaumburg Nutrition and Mental Health (slide share ...
DrRic Whole Foods Market Schaumburg Nutrition and Mental Health (slide share ...DrRic Saguil
 
Diagnostic Testing and Treatment Adventures on Monday Morning: A Wrap-Up
Diagnostic Testing and Treatment Adventures on Monday Morning: A Wrap-UpDiagnostic Testing and Treatment Adventures on Monday Morning: A Wrap-Up
Diagnostic Testing and Treatment Adventures on Monday Morning: A Wrap-UpLouis Cady, MD
 
ADD and ADHD cause cure
ADD and ADHD cause cureADD and ADHD cause cure
ADD and ADHD cause cureJohn Bergman
 

What's hot (20)

Dopa Responsive Dystonia
Dopa Responsive DystoniaDopa Responsive Dystonia
Dopa Responsive Dystonia
 
caffiene and theine
caffiene and theinecaffiene and theine
caffiene and theine
 
Coffee Health Effects and Bioactive compounds
Coffee Health Effects and Bioactive compoundsCoffee Health Effects and Bioactive compounds
Coffee Health Effects and Bioactive compounds
 
Seizures in pediatrics
Seizures in pediatricsSeizures in pediatrics
Seizures in pediatrics
 
Lennox Gastaut Syndrome- by Rxvichu :)
Lennox Gastaut Syndrome- by Rxvichu :)Lennox Gastaut Syndrome- by Rxvichu :)
Lennox Gastaut Syndrome- by Rxvichu :)
 
The Importance of Nutrition for Mental Health: Dr. Alex Richardson -
The Importance of Nutrition for Mental Health: Dr. Alex Richardson - The Importance of Nutrition for Mental Health: Dr. Alex Richardson -
The Importance of Nutrition for Mental Health: Dr. Alex Richardson -
 
Hiccups
HiccupsHiccups
Hiccups
 
Depression
DepressionDepression
Depression
 
Caffeine
CaffeineCaffeine
Caffeine
 
LGS Foundation 2016 Conference - Friday Morning
LGS Foundation 2016 Conference - Friday MorningLGS Foundation 2016 Conference - Friday Morning
LGS Foundation 2016 Conference - Friday Morning
 
Leigh Syndrome - Mary Kay Koenig, MD
Leigh Syndrome - Mary Kay Koenig, MDLeigh Syndrome - Mary Kay Koenig, MD
Leigh Syndrome - Mary Kay Koenig, MD
 
Alzheimer's
Alzheimer'sAlzheimer's
Alzheimer's
 
Caffeine presentation
Caffeine presentationCaffeine presentation
Caffeine presentation
 
Caffeine & ITS effect on brain
Caffeine & ITS effect on brainCaffeine & ITS effect on brain
Caffeine & ITS effect on brain
 
Pediatric Seizures
Pediatric SeizuresPediatric Seizures
Pediatric Seizures
 
Autoimmune epilepsy
Autoimmune epilepsy Autoimmune epilepsy
Autoimmune epilepsy
 
Supplement manual mass
Supplement manual massSupplement manual mass
Supplement manual mass
 
DrRic Whole Foods Market Schaumburg Nutrition and Mental Health (slide share ...
DrRic Whole Foods Market Schaumburg Nutrition and Mental Health (slide share ...DrRic Whole Foods Market Schaumburg Nutrition and Mental Health (slide share ...
DrRic Whole Foods Market Schaumburg Nutrition and Mental Health (slide share ...
 
Diagnostic Testing and Treatment Adventures on Monday Morning: A Wrap-Up
Diagnostic Testing and Treatment Adventures on Monday Morning: A Wrap-UpDiagnostic Testing and Treatment Adventures on Monday Morning: A Wrap-Up
Diagnostic Testing and Treatment Adventures on Monday Morning: A Wrap-Up
 
ADD and ADHD cause cure
ADD and ADHD cause cureADD and ADHD cause cure
ADD and ADHD cause cure
 

Viewers also liked

endosulfan induced neurotoxicity
endosulfan induced neurotoxicityendosulfan induced neurotoxicity
endosulfan induced neurotoxicityHabiba Sheikh
 
Peer Review of Synergistic Effects of Pesticides and Metals in Parkinson's
Peer Review of Synergistic Effects of Pesticides and Metals in Parkinson'sPeer Review of Synergistic Effects of Pesticides and Metals in Parkinson's
Peer Review of Synergistic Effects of Pesticides and Metals in Parkinson'sAfonte4
 
Prenatal Exposure to Pesticides and Child Health Outcomes
Prenatal Exposure to Pesticides and Child Health OutcomesPrenatal Exposure to Pesticides and Child Health Outcomes
Prenatal Exposure to Pesticides and Child Health OutcomesJosh Green
 
Parkinsons disease V Pharm.D
Parkinsons disease V Pharm.DParkinsons disease V Pharm.D
Parkinsons disease V Pharm.DDr.Sohel Memon
 
pesticide-persistence
  pesticide-persistence  pesticide-persistence
pesticide-persistenceGhassan Hadi
 
Pesticidal exposure(haris & jitendra)
Pesticidal exposure(haris & jitendra)Pesticidal exposure(haris & jitendra)
Pesticidal exposure(haris & jitendra)nagarjitendra
 
ORGANOPHOSPHOROUS POISONING NEUROVIEW
ORGANOPHOSPHOROUS POISONING NEUROVIEWORGANOPHOSPHOROUS POISONING NEUROVIEW
ORGANOPHOSPHOROUS POISONING NEUROVIEWSrirama Anjaneyulu
 
Organophosphate poisoning
Organophosphate poisoningOrganophosphate poisoning
Organophosphate poisoningFatma Faris
 

Viewers also liked (15)

endosulfan induced neurotoxicity
endosulfan induced neurotoxicityendosulfan induced neurotoxicity
endosulfan induced neurotoxicity
 
Organophosphate Poisoning
Organophosphate Poisoning  Organophosphate Poisoning
Organophosphate Poisoning
 
Peer Review of Synergistic Effects of Pesticides and Metals in Parkinson's
Peer Review of Synergistic Effects of Pesticides and Metals in Parkinson'sPeer Review of Synergistic Effects of Pesticides and Metals in Parkinson's
Peer Review of Synergistic Effects of Pesticides and Metals in Parkinson's
 
Neurotoxicity
NeurotoxicityNeurotoxicity
Neurotoxicity
 
Pesticide Exposure Presentation
Pesticide Exposure PresentationPesticide Exposure Presentation
Pesticide Exposure Presentation
 
Prenatal Exposure to Pesticides and Child Health Outcomes
Prenatal Exposure to Pesticides and Child Health OutcomesPrenatal Exposure to Pesticides and Child Health Outcomes
Prenatal Exposure to Pesticides and Child Health Outcomes
 
Parkinsons disease V Pharm.D
Parkinsons disease V Pharm.DParkinsons disease V Pharm.D
Parkinsons disease V Pharm.D
 
pesticide-persistence
  pesticide-persistence  pesticide-persistence
pesticide-persistence
 
Organophosphate poisoning
Organophosphate poisoningOrganophosphate poisoning
Organophosphate poisoning
 
Pesticidal exposure(haris & jitendra)
Pesticidal exposure(haris & jitendra)Pesticidal exposure(haris & jitendra)
Pesticidal exposure(haris & jitendra)
 
ORGANOPHOSPHOROUS POISONING NEUROVIEW
ORGANOPHOSPHOROUS POISONING NEUROVIEWORGANOPHOSPHOROUS POISONING NEUROVIEW
ORGANOPHOSPHOROUS POISONING NEUROVIEW
 
Organophosphate poisoning
Organophosphate poisoningOrganophosphate poisoning
Organophosphate poisoning
 
Mouse model: Pros & Cons
Mouse model: Pros & ConsMouse model: Pros & Cons
Mouse model: Pros & Cons
 
Organophosphate poisoning
Organophosphate poisoningOrganophosphate poisoning
Organophosphate poisoning
 
Effects of pesticides of humans
Effects of pesticides of humansEffects of pesticides of humans
Effects of pesticides of humans
 

Similar to my seminar p.p

Similar to my seminar p.p (20)

Parkinsons disease
Parkinsons diseaseParkinsons disease
Parkinsons disease
 
Parkinsonism, Parkinson’s Disease
Parkinsonism, Parkinson’s Disease Parkinsonism, Parkinson’s Disease
Parkinsonism, Parkinson’s Disease
 
Parkinsons paper
Parkinsons paperParkinsons paper
Parkinsons paper
 
Parkinsonism.ppt
Parkinsonism.pptParkinsonism.ppt
Parkinsonism.ppt
 
Parkinson's
Parkinson'sParkinson's
Parkinson's
 
Parkinson’s disease
Parkinson’s diseaseParkinson’s disease
Parkinson’s disease
 
Parkinson's disease Seminar Presentation
Parkinson's disease Seminar PresentationParkinson's disease Seminar Presentation
Parkinson's disease Seminar Presentation
 
Prakash park
Prakash parkPrakash park
Prakash park
 
Parkinson
ParkinsonParkinson
Parkinson
 
Parkinsonism
ParkinsonismParkinsonism
Parkinsonism
 
Nursing management of patient with chronic neurological problems
Nursing management of patient with chronic neurological problemsNursing management of patient with chronic neurological problems
Nursing management of patient with chronic neurological problems
 
Parkinson’S Disease
Parkinson’S DiseaseParkinson’S Disease
Parkinson’S Disease
 
Parkinson's diseases
Parkinson's diseasesParkinson's diseases
Parkinson's diseases
 
Parkisonism and anti parkinson's drugs
Parkisonism and anti parkinson's drugs Parkisonism and anti parkinson's drugs
Parkisonism and anti parkinson's drugs
 
parkinsons disease.pptx
parkinsons disease.pptxparkinsons disease.pptx
parkinsons disease.pptx
 
Anorexia nervosa
Anorexia nervosaAnorexia nervosa
Anorexia nervosa
 
Parkinson's disease by waheed javed
Parkinson's disease by waheed javedParkinson's disease by waheed javed
Parkinson's disease by waheed javed
 
PARKINSONS DISEASE MEDICAL TREATMENT AND PHYSIOTHERAPY MANAGEMENT
PARKINSONS DISEASE MEDICAL TREATMENT AND PHYSIOTHERAPY MANAGEMENT PARKINSONS DISEASE MEDICAL TREATMENT AND PHYSIOTHERAPY MANAGEMENT
PARKINSONS DISEASE MEDICAL TREATMENT AND PHYSIOTHERAPY MANAGEMENT
 
Parkinson’s disease
Parkinson’s diseaseParkinson’s disease
Parkinson’s disease
 
approach to parkinsonism by Dr Ganesh.pptx
approach to parkinsonism by Dr Ganesh.pptxapproach to parkinsonism by Dr Ganesh.pptx
approach to parkinsonism by Dr Ganesh.pptx
 

my seminar p.p

  • 1. DIET AND RISKS OF PARKINSON’S DISEASE Submitted by: Asal Sadeq Submitted to: Dr. Salma Tokan
  • 2.  Introduction:  Parkinson’s disease (PD) also known as idiopathic or primary parkinsonism, hypokinetic rigid syndrome/HRS, or paralysis agitans, is a chronic and progressive movement disorder.  The cause is unknown, and although there is presently no cure. But there are medications and surgery to manage its symptoms.
  • 3. Parkinson’s involves the malfunction and death of vital nerve cells in the brain, called neurons in the an area of the brain called the substantia nigra. Which produce dopamine.
  • 4.
  • 5. Tremor or shaking Small handwriting Loss of smell Trouble sleeping Trouble moving or walking Constipation A soft or low voice Dizziness or fainting Stooping or Hunching over Masked face Signs of Parkinson’s disease
  • 6. RISK FACTORS OF PARKINSON'S DISEASE Age Gender Head injury Exposure to metals Area of residence Occupation Pesticide exposure Solvents and PCBs Genetic
  • 7. AGE About 1% of people over age 60 have Parkinson’s disease compared with 0.001% of people 45 or younger.
  • 8. GENDER Parkinson’s is more common in men than in women and it’s unknown whether this is due to genetic factors, hormones, or differences in behavior.
  • 9. HEAD INJURY Injury that results in amnesia or loss of consciousness has been associated with an increased risk of developing Parkinson’s years after the injury.
  • 10. EXPOSURE TO METALS Occupational exposures to various metals have been suggested to be related to the development of PD.
  • 11. AREA OF RESIDENCE There are differences in the geographic distribution of PD. These could be due to differences in environmental factors.
  • 12. OCCUPATION Certain occupational categories or job titles have been associated with a higher incidence of PD, but results have been inconsistent.
  • 13. PESTICIDE EXPOSURE Of all chemical exposures that have been linked to Parkinson's, pesticides have been reported the most consistently.
  • 14. SOLVENTS AND TCE Occupational exposure to TCE was found to be associated with Parkinson's among workers whose factory results in long term exposure to the solvent.
  • 15. GENETIC PREDISPOSITION Person’s genetic makeup will help to determine the effect of an environmental exposure.
  • 16. PROTECTIVE FACTORS Caffeine Uric acid or urate Nicotine CholesterolVitamin D Antioxidant and mediterrean diet Exercise
  • 17. CAFFEINE There have been several recent studies suggesting that caffeine may reduce the risk of Parkinson's disease. And there is a new study suggesting that caffeine may be a reasonable treatment for the Parkinson's disease motor symptoms. ( Dr. Michael S. Okun, 2012)
  • 18. ASSOCIATIONS OF PARKINSON'S DISEASE WITH CONSUMPTION OF TEA, DECAFFEINATED COFFEE, AND COLA DRINKS, WESTERN WASHINGTON STATE, 1992–2000 AM J EPIDEMIOL VOL. 155, NO. 8, 2002)) 95% CIOR*no. of controls no. of cases Tea (cups/day) 0.6- 1.31.0202138Almost never 0.2-0.90.811061>0-1 0.0320.43511>= 2
  • 19. URIC ACID OR URATE Uric acid is a natural antioxidant that may reduce oxidative stress, a mechanism thought to play a role in the pathogenesis of PD. Higher levels of serum urate may have a neuroprotective effect. High SU levels reduced the risk of developing PD and correlated with slower PD progression. Among PD patients SU level were lower as compared with controls. (Ilana Schlesinger, 2008)
  • 20. NICOTINE Both retrospective and prospective epidemiological studies have consistently demonstrated an inverse association between cigarette smoking and PD, leading to theories that smoking in general and nicotine in particular might be neuroprotective. (ross GW, 2011)
  • 21. ASSOCIATIONS OF PARKINSON'S DISEASE WITH CIGARETTE SMOKING, WESTERN WASHINGTON STATE, 1992–2000 ( AM J EPIDEMIOL,2002) 95% CIOR*No. of controls No. of cases Smoking status 1.0132112Never smoked 0.4-0.80.521598Ever smoked 0.1-0.70.3367Current smoker 0.4-0.90.617991EX- smoker
  • 22. CHOLESTEROL LEVELS  Statins are among the most widely used drug around the world. Beyond lowering cholesterol they are known to fight inflammation and oxidative stress.  When they get into your brain they likely modify the brain’s immune system, Lessing your risk of PD  Finding that when people on certain statins stop taking them, their risk of developing PD is higher. (Lee-YC, 2013)
  • 23. VITAMIN D Two studies of vitamin D and Parkinson’s indicate that those with PD have lower vitamin D blood levels than those without PD. Vitamin D may also reduce inflammation in the brain.
  • 25. ANTIOXIDANTS AND MEDITERRANEAN DIET  Antioxidants “soak up” or scavenge free radicals.  Vitamin C and E are antioxidants that fight free radicals, and may protect brain cells.  Dietary sources include whole grains, wheat germ, avocados, nuts and vegetable oil.
  • 26. MEDITERRANEAN DIET There is some evidence that the Mediterranean diet, a diet high in monounsaturated fats, may be beneficial in reducing blood pressure and cardiovascular disease. The diet emphasizes fish, especially those high in Omega 3 fatty acids, and food containing antioxidant.
  • 27. EXERCISE Greater physical activity has been associated with lower risk of Parkinson's studies in animals also support this.
  • 28. PARKINSON’S AND GASTROINTESTINAL DIFFICULTIES Scientists point to two explanations for these difficulties: The same brain changes in PD cause stiffness and slow of movement. PD affect the nerves that line the digestive tract, called the enteric nervous system.
  • 30. DIFFICULTIES SWALLOWING “DYSPHAGIA” People with Parkinson's tend to swallow less often and less completely, and as a result some 70% have too much saliva, which often pools in their mouth. (Ron Pfeiffer, 2008)
  • 31. CONTROLLING SWALLOWING Sucking in hard candies A atropine eye drops Anti- Parkinson’s medication
  • 32. NAUSEA Nausea or bloating can result when the stomach empties its content into the small intestine too slowly, a condition called gastroparesis. (Ron Pfeiffer, M.D.,2008)
  • 33. CONTROLLING NAUSEA  Avoid orange or acidic beverages  Drink beverages slowly  Avoid fried or sweet food  Eat slowly  Eat small and frequent meals  Try to eat when you feel lees nauseated  Rest after eating  Eat light, bland food  Don’t mix cold and hot food
  • 34. CONSTIPATION  It’s defined as fewer than three bowel movements per week, is perhaps the most widely recognized gastrointestinal symptom of Parkinson’s disease.  In some people with PD, constipation may occur due to the improper functioning of the autonomic nervous system which is responsible for regulating smooth muscle activity.  Medications used to treat Parkinson’s disease can also cause constipation. (Ron Pfeiffer, M.D., 2008)
  • 35. TO AVOID CONSTIPATION  Eat a well-balanced diet with plenty of fiber  Dink a plenty of water  Exercise daily  Drink warm liquids, especially in the morning  Add fruits and vegetables to your diet  Eat whole grain food
  • 36. BLADDER PROBLEMS People with PD may also have bladder problems. The most common difficulty is a frequent and urgent need to urinate, even when the bladder is not full. (Ron Pfeiffer, 2008)
  • 37. DRUGS USED TO TREAT PARKINSON'S Carbidopa-levodopa Dopamine agonists MAO inhibitors COMT inhibitors
  • 38. LEVODOPA-CARBIDOPA It’s converted by enzyme in the brain to produce dopamine. Levodopa is most frequent combined with Carbidopa. But levodopa has not seen to slow disease progression. And this drug has a side effects including: dyskinesia, hallucinations, illusions, nausea, and lightheadedness.
  • 39. DOPAMINE AGONISTS These drugs don’t convert to dopamine in the brain, but instead mimic the effect of dopamine on the brain. May cause side effects like: daytime sleeping, hallucinations and risk taking behavior.
  • 40. MAO INHIBITORS  MAO Inhibitors drugs inhibit an enzyme that breaks down Levodopa thus extending its action.  Used alone or in combination with levodopa- carbidopa, but when added to it, the medications increases the risk of hallucinations.  They have side effects like: the drug may have interactions with other medications and food, blood pressure issues must be monitored carefully, also they may have interaction with antidepressant.
  • 41. COMT INHIBITORS  Catechol O-methyltransferase (COMT) inhibitors allow a larger amount of levodopa to reach the brain, thus raising the dopamine levels there.  Used in conjunction with levodopa- carbidopa.  Side effects include: dyskinesia, hallucination mainly from an enhanced levodopa effect.
  • 42. DIETARY GUIDELINES FOR PD PATIENTS Eating regularly Try to limit sugars Moderate use of salt Drink 8 glasses of water per day Diet should includes plenty of calcium and Vitamin D Diet should includes foods high in fiber.